Suppression of non-specific binding in serological Luminex assays.
about
Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharidesInterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markersAssociation of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinomaDevelopment of a suspension microarray for the genotyping of African swine fever virus targeting the SNPs in the C-terminal end of the p72 gene region of the genomeDevelopment and characterization of a multiplex bead-based immunoassay to quantify pneumococcal capsular polysaccharide-specific antibodiesOptimising the quantification of cytokines present at low concentrations in small human mucosal tissue samples using Luminex assaysElimination of false-positive results in a luminex assay for pneumococcal antibodiesDevelopment of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virusHigh throughput selection of effective serodiagnostics for Trypanosoma cruzi infectionLongitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of HaitiSeroprevalence of 34 human papillomavirus types in the German general population.Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay.Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men.Multiplexed serologic assay for nine anogenital human papillomavirus types.Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models.Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens.Seroepidemiology of Human Polyomaviruses in a US Population.Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study.Highly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantilevers.Race, African ancestry, and Helicobacter pylori infection in a low-income United States population.High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.Helicobacter pylori prevalence and circulating micronutrient levels in a low-income United States population.Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer.Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirusMultiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis.Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoidHuman papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition studyGold-plated magnetic polymers for highly specific enrichment and label-free detection of blood biomarkers under physiological conditions.Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled AnalysisA coding variant in TMC8 (EVER2) is associated with high risk HPV infection and head and neck cancer riskComplex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease.Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin.Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skinIntegration of Multiplex Bead Assays for Parasitic Diseases into a National, Population-Based Serosurvey of Women 15-39 Years of Age in CambodiaAbsence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case-control studyAntibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines.Antibody-profiling technologies for studying humoral responses to infectious agents.Development of a five-plex flow cytometric immunoassay for the simultaneous detection of six coccidiostats in feed and eggs.
P2860
Q23918185-2ABA7D8D-7CA8-4BB1-9E87-3EA3A2D6766DQ24606953-E26CBFA8-1DC1-4E50-A955-A3150948B365Q24644897-927263DA-97D8-4B79-8487-57A29F28A48FQ28270634-D20FCF55-126A-40BF-9CDC-902A9C870EDDQ28387340-38A9B8E7-33E3-4918-8D1E-1107059C5EE8Q28391898-919F5E3A-9BE3-4819-BBF0-D6802E9CE0D0Q28393273-521CFE48-DF60-44AC-8186-C5EDBCA000A5Q28397298-49418A2D-C1B9-4EE6-95BF-1BD43EF9DC43Q28473737-A50E82EC-5837-4AB9-B8D0-2D99824D2027Q28484230-6EF0C8D4-B999-4F38-B22F-A198D20FA1B9Q33345224-CCB377D9-C923-4B89-86DB-00A30ECE61A8Q33619565-FA712276-646C-4756-A80F-FDC4B67A0E95Q33723312-6EC8AA59-10FA-4C12-A0C9-158BAA39BF60Q33797720-98E6AD44-96CC-453B-BB10-D008D1F74E53Q33825698-AF000CED-93E4-49FE-BB8D-667022B24B48Q33981634-56483215-05C7-489B-9DCE-83DBD743858BQ34267871-5AAFC0F6-B64C-4CE9-ACC4-C7CE158E5CD9Q34289887-0A05FEBB-0CC0-4F06-AFBF-2973F46C2655Q34505098-7195E21D-38CA-4E86-B94B-BB2D4327D672Q34542473-13CDAA0C-1BC8-45D4-BADA-4CB250F07225Q34890107-5B3F312D-C71E-4674-9020-73C1B24BAFEBQ34949321-41E23024-FBF1-4872-B9B9-AE8D20CEFA76Q35016793-D6441671-BAC5-4543-A0C4-94C6574D1722Q35024041-1A41484F-A934-4C3A-B978-51F4275D94D3Q35070494-164B143F-441B-41B5-99A6-053662839CDBQ35109451-A9F67187-4DF9-4501-A3DE-5DA2A39427FBQ35131369-5EAA7090-BCCC-488C-B6E5-BF912D901380Q35138647-C4E9C598-79CD-44B3-BB1A-F2DA27D0F318Q35144254-93AF2FBD-1211-4373-B1C5-3D0E58659A36Q35208790-98777A79-88DE-419E-9CB2-84958CDF4B78Q35251609-152A8A2A-F196-491A-B9B7-5E484D98ADFDQ35325994-2AE8E57C-6F1F-45C5-9F5D-914EAD7CDE4EQ35725063-57C9BA58-0342-4ECB-8DCB-D74B7B8938D0Q35976937-DA592D92-EF8D-4F99-88AE-229608059264Q35985028-A7A84FD4-6A36-4FCD-8BB3-F1865D318DA7Q36005592-44D582E7-1297-45F5-A635-F90F2C402E17Q36035685-EB63F839-302A-4B4C-A59F-F237476274E3Q36084292-6E7DF231-6C82-48E2-A035-1DA3C1170197Q36160093-C71AD9DA-5435-40F9-AD63-2C61FBE4B097Q36186081-760F2287-C6C2-4267-824C-028BCE0E7423
P2860
Suppression of non-specific binding in serological Luminex assays.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Suppression of non-specific binding in serological Luminex assays.
@ast
Suppression of non-specific binding in serological Luminex assays.
@en
type
label
Suppression of non-specific binding in serological Luminex assays.
@ast
Suppression of non-specific binding in serological Luminex assays.
@en
prefLabel
Suppression of non-specific binding in serological Luminex assays.
@ast
Suppression of non-specific binding in serological Luminex assays.
@en
P1476
Suppression of non-specific binding in serological Luminex assays.
@en
P2093
Peter Sehr
P304
P356
10.1016/J.JIM.2005.11.008
P577
2005-12-19T00:00:00Z